A Resource for Healthcare and Social Services Professionals
December 16, 2021
12:00 pm–1:30 pm ET
This training will discuss strategies to identify patients experiencing a stimulant overdose and will focus on particular strategies for the care of a patient experiencing an acute psychosis secondary to psychostimulant ingestion. The warning signs of psychostimulant overdose and strategies to mitigate the harm associated with the patient’s psychotic state will be discussed. De-escalation of patients experiencing psychosis secondary to psychostimulant intoxication in the clinic and community setting will be reviewed.
Via Zoom
The Harm Reduction Series is designed to provide care givers and providers with information on best practices for caring for individuals who are actively using substances. The education series will teach ways to expand the treatment continuum to include engaging and keeping people safe when they are actively using substances including alcohol, opioids, stimulants, and tobacco. The series is designed for a broad range of audiences and each module will be presented with an expert from the community to provide insight regarding strategies for engagement and implementation.
This training will discuss strategies to identify patients experiencing a stimulant overdose and will focus on particular strategies for the care of a patient experiencing an acute psychosis secondary to psychostimulant ingestion. The warning signs of psychostimulant overdose and strategies to mitigate the harm associated with the patient’s psychotic state will be discussed. De-escalation of patients experiencing psychosis secondary to psychostimulant intoxication in the clinic and community setting will be reviewed.
The entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction.
Guest Speaker
Joseph Shay, Public Health Specialist
Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Substance Addiction Services.
Boston Medical Center grants 1.50 hours to all RNS who attend and complete the evaluation. Boston Medical Center is approved as a provider of continuing professional development by the American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Boston University School of Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Massachusetts Mental Health Counselors Association, Inc. (MaMHCA) grants 1.50 LMHC CE Credits to LMHCs that attend this activity.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.